Skip to content

Exagen Inc. XGN Accounts Payable

Accounts Payable at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$695.7M-3.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.5B+18.4%
Vor Biopharma logo
Vor BiopharmaVOR
$1.04M-72.1%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$356K-47.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$133.1M-3.5%
Revvity logo
RevvityRVTY
$169.68M-4.7%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s accounts payable?
Exagen Inc. (XGN) reported accounts payable of $4.16M in Q1 2026.
How has Exagen Inc.'s accounts payable changed year-over-year?
Exagen Inc.'s accounts payable decreased by 7.8% year-over-year, from $4.51M to $4.16M.
What is the long-term trend for Exagen Inc.'s accounts payable?
Over 5 years (2020 to 2025), Exagen Inc.'s accounts payable has grown at a 6.6% compound annual growth rate (CAGR), from $3.01M to $4.15M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.